Fortrea Holdings Inc.

General ticker "FTRE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $914.6M (TTM average)

Fortrea Holdings Inc. follows the US Stock Market performance with the rate: 56.2%.

Estimated limits based on current volatility of 4.2%: low 8.51$, high 9.24$

Factors to consider:

  • Total employees count: 18000 as of 2023
  • Current price 30.1% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [13.25$, 27.04$]
  • 2026-12-31 to 2027-12-31 estimated range: [12.42$, 25.19$]

Financial Metrics affecting the FTRE estimates:

  • Positive: with PPE of 41.2 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Positive: 6.64 < Operating cash flow per share per price, % of 7.19
  • Positive: 19.40 < Shareholder equity ratio, % of 20.75 <= 42.68
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 0.91 > -0.63
  • Positive: Inventory ratio change, % of -3.23 <= -0.75

Similar symbols

Short-term FTRE quotes

Long-term FTRE plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $2,696.40MM $2,723.40MM
Operating Expenses $2,858.30MM $2,754.00MM
Operating Income $-161.90MM $-30.60MM
Non-Operating Income $-113.10MM $-952.40MM
Interest Expense $123.80MM $91.40MM
Income(Loss) $-275.00MM $-983.00MM
Taxes $-3.50MM $3.20MM
Profit(Loss)* $-328.50MM $-986.20MM
Stockholders Equity $1,362.40MM $563.50MM
Assets $3,579.20MM $2,715.70MM
Operating Cash Flow $262.80MM $113.50MM
Capital expenditure $25.50MM $25.20MM
Investing Cash Flow $251.60MM $14.40MM
Financing Cash Flow $-497.80MM $-76.30MM
Earnings Per Share** $-3.67 $-10.81

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.